IRBM Reports Breakthrough in Zika Virus Drug Discovery
ROME, Feb. 10, 2026 /PRNewswire/ -- IRBM, a leader in early drug…
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio")…
